Lifesci Capital Lowers Inhibrx (NASDAQ:INBX) to Market Perform
Lifesci Capital downgraded shares of Inhibrx (NASDAQ:INBX – Free Report) from an outperform rating to a market perform rating in a report issued on Tuesday morning, PriceTargets.com reports. Separately, JMP Securities reaffirmed a market perform rating on shares of Inhibrx in a research report on Tuesday. View Our Latest Research Report on INBX Inhibrx Stock […]
More Stories
FT Vest SMID Rising Dividend Ac (NYSEARCA:SDVD) Announces Dividend of $0.14
FT Vest SMID Rising Dividend Ac (NYSEARCA:SDVD – Get Free Report) announced a dividend on Friday, November 22nd,NASDAQ Dividends reports....
Airports of Thailand Public Company Limited (OTCMKTS:AIPUY) Plans Dividend Increase – $0.16 Per Share
Airports of Thailand Public Company Limited (OTCMKTS:AIPUY – Get Free Report) announced a dividend on Saturday, November 23rd,NASDAQ Dividends reports....
Corning Natural Gas (OTCMKTS:CNIG) vs. Centuri (NYSE:CTRI) Financial Comparison
Centuri (NYSE:CTRI – Get Free Report) and Corning Natural Gas (OTCMKTS:CNIG – Get Free Report) are both utilities companies, but...
Critical Analysis: Lucas GC (NASDAQ:LGCL) versus Sangoma Technologies (NASDAQ:SANG)
Institutional & Insider Ownership 39.7% of Sangoma Technologies shares are owned by institutional investors. 14.0% of Sangoma Technologies shares are...
Americans Need $5.3 Million Net Worth to Be Considered Financially Successful: Survey
By Naveen Athrappully Americans have high expectations of what it means to be financially successful but many of them do...
2 Key Congressional Races Still Uncalled in California
By Kimberly Hayek Republicans have secured a trifecta in the November general election, taking control of the Oval Office, House,...